Tenaya Therapeutics, Inc. (TNYA) Free cash flow 2020–2025
Tenaya Therapeutics, Inc. (TNYA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$68.9MFY2025 · since FY2020: -$45.2M → -$68.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$68.9M | +24.7% |
| FY2024 | -$91.5M | +11.4% |
| FY2023 | -$103.3M | +17.4% |
| FY2022 | -$125.1M | -45.5% |
| FY2021 | -$85.9M | -90.1% |
| FY2020 | -$45.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNYA financial trends
TNYA RevenueTNYA Net incomeTNYA Net marginTNYA Gross profitTNYA Gross marginTNYA Operating incomeTNYA Operating marginTNYA Operating cash flowTNYA Capital expendituresTNYA Return on equityTNYA Stock buybacksTNYA Dividends paidTNYA Total assetsTNYA Total liabilitiesTNYA Shareholders’ equityTNYA overview →